Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 50INDUSTRY 3NETWORK 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Lymphoid 6Breast 3CNS 1

Conditions

Breast Neoplasms 2551Triple Negative Breast Neoplasms 436Carcinoma, Non-Small-Cell Lung 339Ovarian Neoplasms 315Neoplasms 281Neoplasm Metastasis 253Colorectal Neoplasms 246Stomach Neoplasms 202Pancreatic Neoplasms 196Prostatic Neoplasms 188Lung Neoplasms 180Melanoma 171Squamous Cell Carcinoma of Head and Neck 140Endometrial Neoplasms 140Head and Neck Neoplasms 124Carcinoma, Renal Cell 118Uterine Cervical Neoplasms 104Esophageal Neoplasms 97Urinary Bladder Neoplasms 92Small Cell Lung Carcinoma 87Sarcoma 85Colonic Neoplasms 80Carcinoma, Hepatocellular 62Carcinoma, Transitional Cell 61Kidney Neoplasms 51Advanced Breast Cancer 51Cholangiocarcinoma 50Liver Neoplasms 47Brain Neoplasms 43Mesothelioma 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Cognitive Dysfunction × Breast × Clear all
NCT04972019 2022-05-02

TCIFCF

Bright Cloud International Corp

Phase NA Unknown
40 enrolled
Breast

Breast Neoplasms, Cognitive Dysfunction

NCT04839588 2022-04-28

TCIFCU

Bright Cloud International Corp

Completed
4 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Cognitive Dysfunction

NCT00387062 2008-06-24

Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment

Posit Science Corporation

Phase 1 Completed
50 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Memory Disorders, Neurobehavioral Manifestations, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡